Melflufen in multiple myeloma: the conclusion matters - Authors' reply

Lancet Haematol. 2022 Apr;9(4):e244-e245. doi: 10.1016/S2352-3026(22)00071-0.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Melphalan / analogs & derivatives
  • Multiple Myeloma* / drug therapy
  • Phenylalanine / analogs & derivatives

Substances

  • melflufen
  • Phenylalanine
  • Melphalan